IPO triumvirate

Three IPOs priced on Thursday. Enzymes developer Genencor (GCOR) raised $126 million through the sale of 7 million shares at $18. The deal, which has a 1.05 million-share overallotment, was underwritten by Merrill Lynch; Chase H&Q; Credit Suisse First Boston; and Salomon Smith Barney. On June 30, GCOR filed to sell 7 million shares at $16-$18, after originally filing on May 5 to raise up to $150 million. ...